Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Weekend vs Weekday Leukemia Admissions

Clin Lymphoma Myeloma Leuk; ePub 2017 Aug 8; Parikh, et al

Patients with acute leukemia were more likely to experience hospital-mortality if they were admitted over the weekend vs during a weekday, according to a study involving nearly 83,000 leukemia admissions. Investigators identified participants diagnosed with leukemia using the 2002-2014 Nationwide Inpatient Sample, looking at weekend/weekday admissions and hospital-mortality. Among the results:

  • Overall, acute leukemia admissions declined by 22% in 2014 vs 2002.
  • In-hospital mortality declined from 19% to 15%.
  • 17% of admissions occurred over the weekend.
  • Hospital mortality rate was 19% among weekend admissions and 16% in those admitted during the week.
  • 28% of weekend admissions received early bone marrow biopsy, compared with 46% of those admitted during the week.
  • Patients who received bone marrow biopsy had 64% lower odds of hospital-mortality.
  • Those admitted to a teaching hospital had 35% lower odds of such.
  • Patients admitted over a weekend had 12% higher odds of hospital-mortality.
  • They were also more likely to experience complications (51% vs 48%).

Citation:

Parikh K, Shah M, Mehta D, Arora S, Patel N, Liu Dx. Increased mortality among patients with acute leukemia admitted on weekends as compared to weekdays. [Published online ahead of print August 8, 2017]. Clin Lymphoma Myeloma Leuk. doi:10.1016/j.clml.2017.07.256.

This Week's Must Reads

Gene sequencing bone marrow in myelodysplastic syndrome, Duncavage EJ et al. N Engl J Med 2018;379:1028-41.

Levofloxacin prophylaxis in ALL, AML , Alexander S, et al. JAMA. 2018;320(10):995-1004

Genetic markers signal poor prognosis in MCL, Obr A et al. Clin Lymphoma Myeloma Leuk. 2018 Aug 23. doi: 10.1016/j.clml.2018.07.282

Disparities in ALL treatment toxicity, Taylor OA et al. Clin Cancer Res. 2018 Sep 11. doi: 10.1158/1078-0432.CCR-18-0939

Leukemia risk after maternal contraception use, Hargreave M et al. Lancet Oncol. 2018 Sep 6. doi: 10.1016/S1470-2045(18)30479-0

Must Reads in Practice Management

Oncology studies lack full disclosure of industry payments, Wayant C et al. JAMA Oncol. 2018 Aug 30. doi: 10.1001/jamaoncol.2018.3738.

Improved myeloma outcomes associated with having prescription drug coverage, Olszewski A et al. J Clin Oncol. 2018 Aug 16. doi: 10.1200/JCO.2018.77.8894

For lymphoma patients, insurance is a matter of life or death , Goldstein JS et al. Blood. 2018 Jul 24. doi: 10.1182/blood-2018-03-839035

Expansion in clinical trial eligibility requested by ASCO, Friends of Cancer and ASCO letter to the FDA